The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable buzz within the healthcare community. This innovative dual GIP and GLP-1 target medication seems to deliver notable improvements in fat loss compared to current therapies. Preliminary research studies have demonstra